Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Repotrectinib, a next generation TRK inhibitor, overcomes TRK resistance mutations including solvent front, gatekeeper and compound mutations
    Meeting Abstract

    Drilon, A.; Zhai, D.; Deng, W.; Zhang, X.; Lee, D.; Rogers, E.; Whitten, J.; Huang, Z.; Graber, A.; Liu, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Meeting Abstract

    Brahmer, J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; Holgado, E.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q.; Gettinger, S.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tim-4(+) tissue-resident macrophages impair antitumor T-cell immunity
    Meeting Abstract

    Chow, A.; Schad, S.; Sharma, S. K.; Budhu, S.; Gupta, A.; Pimentel, C.; Zhong, H.; Lewis, J. S.; Poirier, J. T.; Wolchok, J. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Inter-test variability in tumor mutational burden (TMB) quantification and identification of TMB thresholds
    Meeting Abstract

    Vokes, N.; Alguilar, E. J.; Umeton, R.; Adeni, A.; Sholl, L.; Hellmann, M.; Rizvi, H.; Awad, M.; Van Allen, E.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A bioinformatics framework for high-sensitivity detection and monitoring of oncogenic gene fusions in plasma cfDNA
    Meeting Abstract

    Patel, J.; Hasan, M.; Meng, F.; Jing, X.; Tam, G.; Johnson, I.; Zheng, Y.; Bandlamudi, C.; Stewart, C.; Won, H.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Direct genome editing of patient-derived xenografts for rapid in vivo functional genomics
    Meeting Abstract

    Hulton, C. H.; Costa, E. A.; Rudin, C. M.; Poirier, J. T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Coupling neoantigen specific T cell clonotypes and their molecular phenotypes at the single cell level in resectable anti-PD-1 treated NSCLC
    Meeting Abstract

    Caushi, J. X.; Ji, Z.; Zhang, J.; El Asmar, M.; Anagnostou, V.; Cottrell, T. R.; Chan, H. Y.; Guo, H.; Merghoub, T.; Wolchok, J. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Janne, P. A.; Neal, J. W.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A.; Patel, J.; Gadgeel, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save